Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

6 677 evidences · page 80 / 268

The substantial bio availed levels of zinc, manganese, magnesium, and chromium enable the vegetable to be used in the management of diabetes.

Kenyadiabète (non précisé)publié 2025Biological trace element researchPubMeddocument de 2 observations

0,43 pointsThe agricultural livelihood intervention resulted in a significant decrease of 0.43 points in anticipated HIV stigma over 24 months.

KenyaVIH/sidaobservé 24 monthspublié 2024AIDS (London, England)PubMeddocument de 6 observations

26 %Of 940 children who needed artemether-lumefantrine (AL) treatment, AL was prescribed for 26%.

Kenyapaludismepublié 2008Tropical medicine & international health : TM & IHeurope_pmcdocument de 10 observations

67,9 %Non-use of seat belts was 67.9% in the studied population.

Kenyanon-use of seat beltsobservé 2015publié 2020The Pan African medical journalPubMeddocument de 26 observations

40 cases_per_yearBetween 2008 and 2014, fewer than 40 locally acquired malaria cases per year were reported in the Aseer region.

Kenyapaludismeobservé 2008-2014publié 2016Malaria journaleurope_pmcdocument de 9 observations

1,13 adjusted_relative_riskAfter adjusting for age, work venue, intimate partner violence, depression, and partnership status, the adjusted relative risk of PSA detection associated with hazardous/harmful alcohol use was 1.13 (95% confidence interval, 0.82–1.56).

KenyaVIH/sidapublié 2016Sexually transmitted diseaseseurope_pmcdocument de 3 observations

1 028 clientsFrom January to July 2022, 1028 clients interested in PrEP, PEP and/or STI testing were screened and 829 initiated one or more service: 661 PrEP, 162 PEP and 52 STI testing.

KenyaVIH/sidaobservé January to July 2022publié 2025Journal of the International AIDS SocietyPubMeddocument de 19 observations

0,61 odds_ratioLevels of antibodies to LSA-1 were associated with decreased odds of developing clinical malaria (odds ratio 0.61, 95% CI 0.41–0.89) for every 10-fold increase in antibody levels.

Kenyapaludismepublié 2020The American journal of tropical medicine and hygienePubMeddocument de 6 observations

93,2 %Among 618 enrolled participants, 576 (93.2%) identified access to healthcare as an advantage.

KenyaVIH/sidaobservé From February 2017 to May 2018publié 2026BMC public healthPubMeddocument de 10 observations

1,97 hazard_ratioThe hazard ratio of 6-month mortality was 1.97 for children with CMV DNA ≥1000 IU/mL compared to those with lower-level or undetectable CMV DNA.

Kenyacytomegalovirus (CMV) · VIH/sidapublié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 6 observations

88 %The mean proportion of participants with virological suppression at 2 years was 88% for participants in intervention clinics.

KenyaVIH/sidapublié 2023The lancet. HIVPubMeddocument de 8 observations

27 %Among 2250 pregnant women in Kenya, 27% had high HIV risk scores.

KenyaVIH/sidapublié 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 8 observations

A cognitive-behavioral therapy intervention was more efficacious than healthy lifestyles education in reducing alcohol use among HIV-infected Kenyan outpatient drinkers.

Kenyaalcohol use disorder · VIH/sidapublié 2021Addiction (Abingdon, England)PubMeddocument de 5 observations

0,6 hazard_ratioHIV-exposed, uninfected (CHEU) infants had a lower risk of any respiratory tract infection compared to HIV-unexposed, uninfected (CHUU) infants, with a hazard ratio of 0.60 (95% CI 0.44 to 0.82).

Kenyarespiratory tract infectionspublié 2025BMJ global healthPubMeddocument de 10 observations

1 050 casesAmong 24,418 females who received HIV testing, 1050 (4.3%) tested HIV-positive.

KenyaVIH/sidaobservé May 2018 to August 2019publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations

80,8 %The Xpert Ultra assay yielded an overall combination of sensitivity and specificity of 80.8% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations

2,21 adjusted_prevalence_ratioAt 9 months, HIV-exposed uninfected (HEU) infants had higher prevalence of microcephaly (adjusted prevalence ratio: 2.21).

Kenyamicrocephalyobservé 9 monthspublié 2022AIDS (London, England)PubMeddocument de 9 observations

89 %Microscopy demonstrated a specificity of 89% compared to peripheral blood quantitative polymerase chain reaction in diagnosing malaria in pregnancy.

Kenyapaludismeobservé April 2023-March 2024publié 2026BMC infectious diseasesPubMeddocument de 14 observations

62 %HPV awareness was 62.0% among mothers of adolescent girls in Western Kenya.

Kenyainfection à HPVpublié 2021The Pan African medical journalPubMeddocument de 5 observations

6,5 %HBV prevalence was 6.5% among those in informal low risk jobs.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

9 scoreThe median Self-Reporting Questionnaire 20-item (SRQ-20) screening score among adolescent girls and young women (AGYW) was 9.

Kenyacommon mental disorders (CMDs)publié 2025PloS onePubMeddocument de 4 observations

54 %HIV-specific CD8(+) T-cell responses were detected in 25 of 46 participants (54%) before HIV acquisition.

KenyaVIH/sidapublié 2010AIDS (London, England)europe_pmcdocument de 2 observationsDOI 10.1097/qad.0b013e3283391d40

5,4 %Pfcrt CVIET haplotype was detected at a frequency of 5.4%.

Kenyapaludismepublié 2025Malaria journalPubMeddocument de 12 observations

1 %Chlamydia trachomatis and Neisseria gonorrhoeae coinfection prevalence during pregnancy was 1% among 221 pregnant women in Kenya.

KenyaChlamydia trachomatispublié 2026Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 8 observations

9,1 %Viral load monitoring reduced vertical transmission by 9.1–14.3% in known positive women in Kenya.

KenyaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 6 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.